1. Home
  2. NAMS vs GFF Comparison

NAMS vs GFF Comparison

Compare NAMS & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$30.14

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Griffon Corporation

GFF

Griffon Corporation

HOLD

Current Price

$71.48

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAMS
GFF
Founded
2019
1959
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.8B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
NAMS
GFF
Price
$30.14
$71.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$46.75
$101.50
AVG Volume (30 Days)
865.3K
274.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
1.29%
EPS Growth
N/A
N/A
EPS
N/A
1.41
Revenue
N/A
$2,519,926,000.00
Revenue This Year
$25.64
N/A
Revenue Next Year
$530.85
N/A
P/E Ratio
N/A
$48.35
Revenue Growth
N/A
N/A
52 Week Low
$14.06
$63.92
52 Week High
$42.00
$97.58

Technical Indicators

Market Signals
Indicator
NAMS
GFF
Relative Strength Index (RSI) 44.69 35.79
Support Level $29.73 $66.36
Resistance Level $31.72 $72.65
Average True Range (ATR) 1.62 2.14
MACD -0.07 -0.65
Stochastic Oscillator 50.55 25.43

Price Performance

Historical Comparison
NAMS
GFF

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

Share on Social Networks: